Other Species / Isoforms
  SIK (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K20-sm
GQGQGQQkPLRVGFY
0 1
SIK (human) GQGQGQQkPLRVGFY K20-sm
SIK (mouse) GTGQGQQKPLRVGFY K20
SIK (rat) GTGQGQQKPLRVGFY K20
T32-p
GFYDIERtLGKGNFA
0 1
SIK (human) GFYDIERtLGKGNFA T32-p
SIK (mouse) GFYDVERTLGKGNFA T32
SIK (rat) GFYDVERTLGKGNFA T32
T182-p
KSGEPLStWCGSPPY
Upstream
5 0
Kinase, in vitro:
  • LKB1 (human)
Putative in vivo kinases:
  • LKB1 (human)
SIK (human) KSGEPLStWCGSPPY T182-p
SIK (mouse) KPGEPLStWCGSPPY T182-p
SIK (rat) KPGEPLStWCGsPPY T182-p
S186
PLStWCGSPPYAAPE
2 0
SIK (human) PLStWCGSPPYAAPE S186
SIK (mouse) PLStWCGSPPYAAPE S186
SIK (rat) PLStWCGsPPYAAPE S186-p
T322
LGVDRQRTVESLQNS
1 0
SIK (human) LGVDRQRTVESLQNS T322
SIK (mouse) LGIDRQRTIESLQNS T322
SIK (rat) LGIDRQRtVESLQNS T322-p
S370-p
RPRSSDLsGLEVPQE
0 1
SIK (human) RPRSSDLsGLEVPQE S370-p
SIK (mouse) QLRSSDLSSLEVPQE S373
SIK (rat) QLRNSDLSSLEVPQE S373
S435-p
VFRPRPVsPsSLLDT
Upstream
1 13
Treatment
  • LPA
  • selumetinib
  • vemurafenib
SIK (human) VFRPRPVsPsSLLDT S435-p
SIK (mouse) VFRHRSIsPSSLLDT S437-p
SIK (rat) VFRHRSISPSSLLDT S437
S437-p
RPRPVsPsSLLDTAI
Upstream
0 2
Treatment
  • LPA
SIK (human) RPRPVsPsSLLDTAI S437-p
SIK (mouse) RHRSIsPSSLLDTAI S439
SIK (rat) RHRSISPSSLLDTAI S439
T460-p
GLEEEQDtQESLPSS
0 1
SIK (human) GLEEEQDtQESLPSS T460-p
SIK (mouse) SLEEEQEVQEPLPGS V462
SIK (rat) SLEEEQEVQEPLPGS V462
T473-p
SSTGRRHtLAEVStR
1 4
SIK (human) SSTGRRHtLAEVStR T473-p
SIK (mouse) GSTGRRHtLAEVSTH T475-p
SIK (rat) GSTGRRHtLAEVSTH T475-p
T479-p
HtLAEVStRLSPLTA
0 1
SIK (human) HtLAEVStRLSPLTA T479-p
SIK (mouse) HtLAEVSTHFSPLNP T481
SIK (rat) HtLAEVSTHFSPLNP T481
S516-p
LTFSASKsPAGLSGT
0 1
SIK (human) LTFSASKsPAGLSGT S516-p
SIK (mouse) LPFSASEGPAGLGSG G518
SIK (rat) LPFSASEGPAGLGGG G518
S534-p
QGLLGACsPVRLASP
0 2
SIK (human) QGLLGACsPVRLASP S534-p
SIK (mouse) PGLLGTSSPVRLASP S536
SIK (rat) PGLLGTSSPVRLASP S536
S575-p
FQEGRRAsDtSLTQG
8 22
SIK (human) FQEGRRAsDtSLTQG S575-p
SIK (mouse) FQEGRRAsDTSLTQG S577-p
SIK (rat) FQEGRRAsDTSLTQG S577-p
T577-p
EGRRAsDtSLTQGLk
0 1
SIK (human) EGRRAsDtSLTQGLk T577-p
SIK (mouse) EGRRAsDTSLTQGLK T579
SIK (rat) EGRRAsDTSLTQGLK T579
K584-sm
tSLTQGLkAFRQQLR
0 1
SIK (human) tSLTQGLkAFRQQLR K584-sm
SIK (mouse) TSLTQGLKAFRQQLR K586
SIK (rat) TSLTQGLKAFRQQLR K586
K604-sm
KGFLGLNkIKGLARQ
0 1
SIK (human) KGFLGLNkIKGLARQ K604-sm
SIK (mouse) KGFLGLNKIKGLARQ K606
SIK (rat) KGFLGLNKIKGLARQ K606
S626-p
RASRGGLsPFHAPAQ
0 3
SIK (human) RASRGGLsPFHAPAQ S626-p
SIK (mouse) RTPRGGMSTFHTPAP S627
SIK (rat) RGSRGGMSTFHTPAP S627
S634-p
PFHAPAQsPGLHGGA
0 2
SIK (human) PFHAPAQsPGLHGGA S634-p
SIK (mouse) TFHTPAPSSGLQGCT S635
SIK (rat) TFHTPAPSSGLQGCT S635
S644-p
LHGGAAGsREGWSLL
0 1
SIK (human) LHGGAAGsREGWSLL S644-p
SIK (mouse) LQGCTTSNREGRSLL N645
SIK (rat) LQGCTASSREGRSLL S645